Lumida
/NHC
⌘K
National Healthcare Corp

National Healthcare Corp

NHC
$224.47USD-0.20%-0.45 today

MARKET CAP

3.5B

P/E (TTM)

28.6x

FWD P/E

DAY RANGE

$223 – $228

52W RANGE

$114
$239

AI Summary

Stalk
StalkMedium

Stalk for a pullback entry as the primary bullish trend remains intact but short-term timing is unfavorable; medium-term bias is bullish, reinforced by higher highs and higher lows, awaiting acceptance at the rising 50-day SMA near prior support levels.

  • Q2 revenue $408M and EPS $1.74 demonstrate robust growth.
  • Annualized dividend $2.68 yields 1.2%, underlining payout consistency.
  • Rising operating costs pressure profit margins, risking margin compression.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.1B$1.1B$1.1B$1.3B$1.5B
YoY %+4.5%+1.1%+5.1%+14.5%+16.1%
P / Sales1.0x0.8x1.3x1.3x1.4x
EV / Sales1.3x1.2x1.5x1.6x1.6x
Gross Profit, Adj.$1.1B$1.1B$1.1B$1.3B$1.5B
YoY %+4.5%+1.1%+5.1%+14.5%+16.1%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit1.3x1.2x1.5x1.6x1.6x
EBITDA, Adj.$100.7M$69.2M$99.5M$131.9M$173.3M
YoY %+9.9%-31.2%+43.7%+32.6%+31.4%
Margin %9.4%6.4%8.7%10.1%11.4%
EV / EBITDA14.3x18.2x17.4x16.2x14.5x
EBIT$51.8M$28.7M$57.5M$89.9M$128.4M
YoY %+1.0%-44.5%+100.0%+56.5%+42.8%
Margin %4.8%2.6%5.0%6.9%8.5%
EV / EBIT27.7x43.9x30.1x23.8x19.5x
Net Income$138.6M$22.4M$66.8M$101.9M$120.0M
YoY %+231.0%-83.8%+197.6%+52.6%+17.7%
Net Margin12.9%2.1%5.9%7.8%7.9%
EPS (GAAP)$8.99$1.45$4.34$6.53$7.67
YoY %+230.5%-83.9%+199.3%+50.5%+17.5%